Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 4, 2009, Pages 240-243

  Santoro, Rita ^a   Lannaccaro, Piergiorgio ^a   Prejano, Simona ^a   Muleo, Gaetano ^a  

^a NONE

Author keywords

Adverse outcomes; Low molecular weight heparin; Pregnancy; Safety; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; NADROPARIN;

ARTERY THROMBOSIS; ARTICLE; BLEEDING; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; FEMALE; FETUS WASTAGE; FRACTURE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN ALLERGY; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; SUPERFICIAL THROMBOPHLEBITIS; THROMBOCYTOPENIA; THROMBOPHILIA; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; FEMALE; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDIES; THROMBOPHILIA; TIME FACTORS;

EID: 67649522048     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283299c02     Document Type: Article

References (16)

1. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Ches. 2004; 126:627-644.
2. Hunt BJ, Doughty HA, Majundar G, Copplestone A, Kerslake S, Buchanan N, et al. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Haemos. 1997; 77:39-43.
3. Gris JC, Lissalde-Lavigne G, Quére I, Dauzat M, Marés R. Prophylaxis and treatment of thrombophilia in pregnancy. Curr Opin Hemato. 2006; 13:376-381.
4. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lance. 1996; 348:913-916.
5. Grandone E, Margaglione M, Colaizzo D, D'Addedda M, Cappucci G, Vecchioni G, et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemos. 1997; 77:822-824.
6. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. W Engl J Me. 1999; 340:9-13.
7. Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemos. 2004; 91:700-711.
8. Kovalevsky G, Gracia CR, Berlin JA, Sammel M, Barnhart KT. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss. Arch Intern Me. 2004; 164:558-563.
9. Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemos. 2003; 1:433-438.
10. Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J, for the Live-Enox Investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss. The LIVE-ENOX study. J Thromb Haemos. 2005; 3:227-229.
11. Brenner B. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications: yes. J Thromb Haemos. 2003; 1:2070-2072.
12. Sanson BJ, Lensing AWA, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne- Pardonge E, et al. Safety of low molecular weight heparin in pregnancy: a systematic review. Thromb Haemos. 1999; 81:668-772.
13. Sottilotta G, Oriana V, Latella C, Luise F, Piromalli A, Ramirez F, et al. Genetic prothrombotic risk factors in women with unexplained pregnancy loss. Thromb Re. 2006; 117:681 -684.
14. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Bloo. 2005; 106:401-407.
15. Bar J, Mashiah R, Cohen-Sacher B, Hod M, Orvieto R, Ben-Rafael Z, et al. Effect of thromboprophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complication. Thromb Re. 2001; 101:235-241.
16. Gris JC, Mercier E, Quéré I, Lavigne-Lissalde G, Cochery-nouvellon E, Hoffet M, ef al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Bloo. 2004; 103:3695-3699.